Penapisan Senyawa Antimalaria yang Berasal dari Tumbuhan



Efforts to discover and develop new antimalarial drugs have increased dramatically in recent years mainly because of the parasites’ resistance to existing antimalarial drugs. Selection of drug candidates for clinical trials in man and the design of clinical protocols are based upon consideration of data from a battery of preclinical test systems. All compounds are assessed initially in one or more primary models. A compound which is considered active by well established criteria in primary screening test is considered for further evaluation in successively more rigorous clinical test. At the end of each stage of testing, a decision is taken to advance the compound to the next stage or to discontinue it. Primary screening tests should have optimal sensitivity, a high degree of reproducibility, high throughput, should require a minimum quantity of test compound and bear low cost. As there is growing need for newer and more efficacious antimalarial drugs escpecially in tropical countries, more sensitive and economical screening models are needed. This review is an update of various conventional and latest in vitro and in vivo screening methods being used for evaluation of antimalarial compounds.


1. Mustofa. Molekul antimalarial alami: potensi dan tantangan pengembangannya sebagai obat baru untuk malaria. MOT. 2003.8(26):8-18.

2. Rieckmann KH, Sax LJ , Cam GH, Mrema JE. Drug susceptibility of Plasmodium falciparum. An in vitro microtechnique. Lancet 1 .1978:22-3.

3. Desjardins RE, Caniield CJ, Haynes DE, Chulay JD. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979.(16):710-8.

4. Mackler MT, Hinrichs DJ. Measurement of lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. Am J Trop Med. 1993.(48):205-10.
5. Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976.(193):673-5.

6. Dennis E, Kyle H, Webster K. In vitro antimalarial drug susceptibility. 2002.

7. Makler MT, Ries JM, Wiliams JA, et al. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am J Trop Med. 1993. 48(6):739-41.

8. Markell EK, Voge M, John DT. Medical parasitology. 6th ed. Philadeplphia: WB Saunders Company; 1986.

9. Iqbal J, Hira P, Sher A, Al-Eneji A. Diagnosis of imported malaria by Plasmodium lactate dehydrogenase (pLDH) and histidine-rich protein-2 (PtHRP-2)-based immunocapture assays. Am J Trop Med. 2001.64(1):20-3

10. Peters W. Techniques for the study of drug response in experimental malaria, chemotherapy and drug resistance in malaria. New York: Academic; 197O.p.64-136.

11. O’Neill MJ. Bray DH, Boardman P, Phillipson JD, Warhurst DC. Plants as sources of antimalarial drugs, part I: in vitro test method for the evaluation of crude extract from plants. Plant. Med. 1985.(5):384-397.

12. Phillipson JD. Assays for antimalarial and amoebicidal activities. In: Dey PM, Harborne JB. Methods in plants biochemistry. Vol. 6. Assays for bioactivity. London: Academic Press Harcourt Brace Jovanovich Publisher; 1991.p.135-52.

13. Wernsdorfer WH, Payne D. Drug sensitivity test in malaria parasites. In: Wernsdorfer WH and Mc Gregor. Malaria principles and practice on malariology. Vol. II. London: Churchill; 1988.p.1765-92.
How to Cite
SYAMSUDIN, SYAMSUDIN. Penapisan Senyawa Antimalaria yang Berasal dari Tumbuhan. JURNAL ILMU KEFARMASIAN INDONESIA, [S.l.], v. 6, n. 2, p. 95-99, sep. 2008. ISSN 2614-6495. Available at: <>. Date accessed: 23 june 2024.